Neurotransmitter & precursor to the neurotransmitter linked lawsone derivatives: design, synthesis, molecular docking, and evaluation of antidiabetic potential
Future Medicinal Chemistry · 03.06.2026 · 18 (11) · 1317-1330
DOI: 10.1080/17568919.2026.2658013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, online erschienen am 26.05.2026. Verfasst von S Monica und 2 weiteren Autor:innen. Beteiligte Einrichtung: PG and Research Department of Chemistry, The Standard Fireworks Rajaratnam College for Women (Affiliated to Madurai Kamaraj University, Madurai), Siv…. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Hypoglycemic Agents, Drug Design, Glycoside Hydrolase Inhibitors. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aims
Type 2 diabetes mellitus (T2DM) is an increasingly prevalent worldwide health problem, and new antidiabetic agents are needed to address the limitations of current therapies. The research aims to create and assess hybrid compounds based on lawsone that contain neurochemical frameworks as potential agents for treating T2DM.Patients and methods/materials and methods Hydroxy naphthoquinone–based hybrids were synthesized using dopamine and tryptophan and characterized by spectral techniques. Density Functional Theory (DFT/B3LYP) calculations were performed to analyze molecular geometry, electrostatic potential, and spectral properties. Antioxidant activity was assessed for reactive oxygen species (ROS) scavenging. Drug-likeness was predicted using SwissADME. Molecular docking was conducted against α-amylase (PDB: 4W93) and α-glucosidase (PDB: 2ZE0), followed by in vitro enzyme inhibition assays using acarbose as a reference.
Results
Hybrids demonstrated impressive antioxidant properties as well as acceptable pharmacokinetics. Using docking studies, it is clear that hybrids bind stably to the active sites of enzymes based on important interactive forces. Additionally, both hybrids were found to inhibit α-amylase and α-glucosidase in vitro, where inhibiting both acted in a dose-dependent manner.
Conclusions
Hybrids that are derived from lawsone show promise for being multifunctional agents for treating diabetes, and they should be evaluated further in preclinical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PG and Research Department of Chemistry, The Standard Fireworks Rajaratnam College for Women (Affiliated to Madurai Kamaraj University, Madurai), Sivakasi, India.
- PG and Research Department of Chemistry, University College (Affiliated to Kerala University), Thiruvananthapuram, India.
Zitieren
APA
Monica, S., Kavitha Rani, P. R., & Hari Prasad, S. (2026). Neurotransmitter & precursor to the neurotransmitter linked lawsone derivatives: design, synthesis, molecular docking, and evaluation of antidiabetic potential. Future Medicinal Chemistry, 18(11), 1317-1330. https://doi.org/10.1080/17568919.2026.2658013
Vancouver
Monica S, Kavitha Rani PR, Hari Prasad S. Neurotransmitter & precursor to the neurotransmitter linked lawsone derivatives: design, synthesis, molecular docking, and evaluation of antidiabetic potential. Future Medicinal Chemistry. 2026;18(11):1317-1330. doi:10.1080/17568919.2026.2658013
BibTeX
@article{Monica2026,
author = {Monica, S and Kavitha Rani, P R and Hari Prasad, S},
title = {Neurotransmitter & precursor to the neurotransmitter linked lawsone derivatives: design, synthesis, molecular docking, and evaluation of antidiabetic potential},
journal = {Future Medicinal Chemistry},
year = {2026},
volume = {18},
number = {11},
pages = {1317--1330},
doi = {10.1080/17568919.2026.2658013}
}
EUVIMED